MichelleAshworthMD

PubMed

• Melanoma immunotherapy.
  Sanlorenzo, M.,Vujic, I.,Posch, C.,Dajee, A.,Yen, A.,Kim, S.,Ashworth, M.,Rosenblum, M. D.,Algazi, A.,Osella-Abate, S.,Quaglino, P.,Daud, A.,Ortiz-Urda, S.> ;Cancer Biol. Ther.. 2014 Mar 22
• 149 citations
  Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
  Adil Daud, Michelle T. Ashworth, Jonathan Strosberg, Jonathan W. Goldman, David S. Mendelson, Gregory M. Springett, Alan P. Venook, Sabine Loechner, Lee S. Rosen, Fran...> ;Journal of Clinical Oncology. 2015 Mar 20
• 70 citations
  Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial
  Alexander M. Menzies, Michelle T. Ashworth, Suzanne Swann, Richard F. Kefford, Keith T. Flaherty, J.S. Weber, J. R. Infante, Kevin B. Kim, Rene Gonzalez, Omid Hamid, L...> ;Annals of Oncology. 2015 Feb 1
• 3 citations
  Combinatorial approach to treatment of melanoma.
  Michelle T. Ashworth, Adil Daud> ;Hematology/oncology Clinics of North America. 2014 Jun 1
• Management of a Patient With Advanced BRAF-Mutant Melanoma
  Michelle T. Ashworth, Adil Daud> ;Journal of the National Comprehensive Cancer Network. 2014 Mar 1
• Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
  Allen CE Li L Peters TL Leung HC Yu A Man TK Gurusiddappa S Phillips MT Hicks MJ Gaikwad A Merad M McClain KL> ;J Immunol. 2010 Apr 15
• Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.
  Phillips M Allen C Gerson P McClain K> ;Pediatr Blood Cancer. 2009 Jan
• Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100).
  Daud, A.,Algazi, A.,Ashworth, M.,Buljan, M.,Takamura, K. T.,Diep, T.,Pierce, R. H.,Bhatia, S.> ;J Transl Med. 2015 Mar 18
• Join now to see all

Abstracts/Posters

• 18F-fluorodeoxyglucose PET/CT imaging for predicting treatment response in patients with advanced melanoma treated with anti-PD1 immunotherapy.
  Miguel Hernandez Pampaloni, Michelle T. Ashworth, Alain Patrick Algazi, Adil Daud; University of California San Francisco, San Francisco, CA; University of California,..., 2014 ASCO Annual Meeting General Poster Session, Developmental Therapeutics - Immunotherapy, Chicago, IL, 6/1/2014